(Q54391854)

29 May 2018

title

Clinical relevance of cytomegalovirus viraemia(*,†). (English)

1 reference

29 May 2018

main subject

Cytomegalovirus

0 references

author

Swiss HIV Cohort Study

13

object named as

Swiss HIV Cohort Study

1 reference

29 May 2018

0 references

E Boffi El Amari

1

1 reference

29 May 2018

C Combescure

2

1 reference

29 May 2018

S Yerly

3

1 reference

29 May 2018

A Calmy

4

1 reference

29 May 2018

L Kaiser

5

1 reference

29 May 2018

B Hasse

6

1 reference

29 May 2018

H Furrer

7

1 reference

29 May 2018

M Cavassini

8

1 reference

29 May 2018

P Vernazza

9

1 reference

29 May 2018

Hh Hirsch

10

1 reference

29 May 2018

E Bernasconi

11

1 reference

29 May 2018

B Hirschel

12

1 reference

29 May 2018

publication date

19 January 2011

1 reference

29 May 2018

published in

HIV Medicine

1 reference

29 May 2018

volume

12

1 reference

29 May 2018

issue

7

1 reference

29 May 2018

page(s)

394-402

1 reference

29 May 2018

Cytomegalovirus viraemia in the modern antiretroviral era(*).

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy. Spanish CMV-AIDS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Cytomegalovirus viraemia has poor predictive value for the development of cytomegalovirus disease in patients with advanced HIV-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Improved monitoring of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation by an ultrasensitive plasma DNA PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Time-dependent ROC curves for censored survival data and a diagnostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Concurrent CMV and EBV DNAemia is significantly correlated with a delay in the response to HAART in treatment-naive HIV type 1-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

CMV as a cofactor enhancing progression of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Cytomegalovirus reactivation in critically ill immunocompetent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Cytomegalovirus viral load testing of blood using quantitative polymerase chain reaction in acutely unwell HIV-1-positive patients lacks diagnostic utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

Cellular Immunity and Active Human Cytomegalovirus Infection in Patients with Septic Shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2010.00900.X

10.1111/J.1468-1293.2010.00900.X

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

21251182

1 reference

29 May 2018